CClinicalTrials.gg
Sign In
Status unknownNCT05153512AdodreamUpdated Dec 10, 2021

ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging (Adodream)

An observational study in Endometriosis, sponsored by Ramsay Générale de Santé. Status unknown at 1 site in France. Open to female participants aged 12 Years to 20 Years. Per ClinicalTrials.gov, last updated 2021-12-10.

Sponsored by Ramsay Générale de Santé · Observational

The sponsor has not verified this record recently (last verified Dec 2021), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
350
Ages
12 Years to 20 Years
Sex
Female
01

Study summary

To date, no MRI study has been published describing the prevalence of endometriosis in adolescent girls, not even in those with significant dysmenorrhea and therefore more particularly at risk. Likewise, there are no precise data on the type of superficial or early-onset deep endometriosis that appears in adolescence. The collection of these data would allow an earlier diagnosis, because it is better documented, of endometriosis. The lesions would then be treated earlier, avoiding their development and the problems of infertility related to this pathology. The aim of this sudy is to assess the prevalence of endometriosis and its phenotypic representation in the study population consulting for dysmenorrhea with suspected endometriosis.

02

Conditions studied

  • Endometriosis
03

In context

Endometriosis

901 studies on the registry are indexed under Endometriosis; 259 are open to participants now.

This study's planned enrollment of 350 is above the median of 128 across 344 observational studies indexed under Endometriosis.

Browse Endometriosis studies →

Lead sponsor

Ramsay Générale de Santé is the lead sponsor of 42 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 20 Years
Sexes eligible
Female
Sampling method
Non-probability sample

Study population

Women between 12 and 20 years-old and suffering from dysmenorrhea

Inclusion criteria

  • Patient aged between 12 and 20 years old.
  • After menarche.
  • Requiring pelvic MRI for exploration of dysmenorrhea (after or not ultrasound), in the case of patients with suspected endometriosis, or for any other reason (cyst, tumor, non-obstructive urogenital malformations), in the case of patients without symptoms clinic associated with endometriosis.
  • Patient affiliated or beneficiary of a social security scheme.
  • Patient and her legal representative, if applicable, having been informed and not opposing this research.

Exclusion criteria

Exclusion Criteria:

  • Patient whose pelvic MRI is performed as part of an exploration of obstructive uterine malformations.
  • Patient claustrophobic, making it impossible to perform an MRI.
  • Contraindication to MRI: pacemaker, ferromagnetic object incompatible with MRI.
  • Pregnant, breastfeeding or parturient woman.
  • Protected patient: Major under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision; Hospitalized without consent.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
350 participants (estimated)
Patient registry
No

Interventions

  • ProcedureMRI

    Pelvic MRI without injection of contrast product and WITHOUT rectal or vaginal opacification

06

What researchers measure

Primary outcomes

  1. Number of patient with endometriosis detected on MRI

    Time frame: 1 day

07

Study locations

1 of 1 sites recruiting
  • BLOMET clinic
    Paris, IDF 75015, France
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 10, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05153512
Lead sponsor
Ramsay Générale de Santé
Collaborators
European Clinical Trial Experts Network
Responsible party
Sponsor
First posted
Dec 10, 2021
Start date
Sep 26, 2019
Primary completion
Jun 26, 2020
Completion
Dec 26, 2021 (estimated)
Last update
Dec 10, 2021

Study contacts

Jean-François Oudet
Contact
jf.oudet@ecten.eu
0683346567
Marie-Hélène Barba
Contact
mh.barba@ecten.eu

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Endometriosis→

Other studies from this sponsor

Ramsay Générale de Santé

Start the discussion